Intrinseque Health
Nitin Jain is the President & CEO at Intrinseque Health, a Global Drug Development Support Organisation specializing in Clinical Supply Chain Solutions. Previously, Nitin has held various executive positions in companies such as Ancillare, LP, Worldwide Clinical Trials, Quramax Limited, Theorem, Covance, INC Research, Lambda Therapeutic Research, and Deepharma Limited. Nitin has a MBA in Marketing from ACL, London, UK and a BBA in Marketing from AMLA, Los Angeles, USA.
This person is not in any teams
Intrinseque Health
Founded and managed by Drug Development industry professionals, Intrinseque Health is an EN ISO 13485:2016 certified, Global Clinical Development support organization, assisting biopharmaceutical, biotechnology and drug development companies with their clinical development programs. Drug Development industry professionals, who understand the hurdles and pain-points of conducting a clinical trial. In order to ensure that medical devices, equipment and supplies reach sites on time, are installed & calibrated (IQ OQ PQ), site officials are trained on ‘instructions of use’, development of a robust supply chain strategy and management of ancillary supplies at sites for entire duration of life-cycle of a clinical trial is a must but is often undermined which, affects the study timelines. Every region/country presents its own unique regulatory & logistical challenges while ensuring product/supplies/equipment available for a clinical study. Intrinseque Health provides Project Management-based, global clinical supply chain solutions to its clients. Our Operation Methodology is based on development of a pressure-tested/full-proof & cost effective clinical supply chain strategy for each clinical trial / project. We believe in engaging at an early stage with our clients for their clinical & non-clinical supply needs, before initiation of a clinical trial.